Showing 1191-1200 of 2843 results for "".
Headache Horizons: Reversible Cerebral Vasoconstriction Syndrome: Presentation, Diagnosis, and Treatment of a Complex Neurovascular Disorder
https://practicalneurology.com/diseases-diagnoses/headache-pain/headache-horizons-reversible-cerebral-vasoconstriction-syndrome-presentation-diagnosis-and-treatment-of-a-complex-neurovascular-disorder/32145/Early diagnosis of and intervention for reversible cerebral vasoconstriction syndrome produce a more favorable outcome, limiting potentially disabling or fatal sequelae.Neuroinflammation in Parkinson Disease
https://practicalneurology.com/diseases-diagnoses/movement-disorders/neuroinflammation-in-parkinson-disease/31826/Neuroinflammation plays multiple roles in the pathogenesis of Parkinson disease.Is There a Place for Spirituality in Neurology?
https://practicalneurology.com/columns/practice-management/is-there-a-place-for-spirituality-in-neurology/31937/Being comfortable with spirituality may improve care in multiple ways.An Update on the Management of Chronic Migraine
https://practicalneurology.com/diseases-diagnoses/headache-pain/an-update-on-the-management-of-chronic-migraine/30697/In 1672, Thomas Willis provided the first description of chronic migraine (CM) when he reported the case of the philosopher, Anne, Viscountess Conway, who was also treated by William Harvey and Robert Boyle without success.1-4 Has our treatment of chronic migraine since improved?- Neurosurgery Device Platform Receives 510(k) Clearance from the FDAhttps://practicalneurology.com/news/neurosurgery-device-platform-receives-510k-clearance-from-the-fda/2470564/The Food and Drug Administration (FDA) has granted 510(k) clearance to the Neuroblade System (Clearmind Biomedical, San Jose, CA), a neuroendoscopy platform designed for minimally invasive neurosurgical procedures, integrating multiple functions and external devices to provide visualization, illu
- FDA Grants 510(k) Clearance to New AI-Based White Matter Imaging Technologyhttps://practicalneurology.com/news/fda-grants-501k-clearance-to-new-ai-based-white-matter-imaging-technology/2470260/The Food and Drug Administration (FDA) has granted 510(k) clearance to a new software tool called Advanced Neuro Diagnostic Imaging (ANDI) (Imeka, Sherbrooke, Canada), which analyzes diffusion-weighted imaging (DWI) using a
- FDA Grants 510(k) Clearance to Thin-Film SEEG-Guided Radiofrequency Ablation System for Neurosurgeryhttps://practicalneurology.com/news/fda-grants-510k-clearance-to-thin-film-seeg-guided-radiofrequency-ablation-system-for-neurosurgery/2470363/The Food and Drug Administration (FDA) has granted 510(k) clearance to the OneRF Ablation System (NeuroOne, Eden Prairie, MN), according to an announcement from NeuroOne. The OneRF Ablation System produces radiofrequencies that generate heat to ablate nervous tissue for use in neurosurgery, with
- AI-Based Brain Volumetric Software, VUNO Med-DeepBrain, Receives FDA 510(k) Clearancehttps://practicalneurology.com/news/ai-based-brain-volumetric-software-vuno-med-deepbrain-receives-fda-510k-clearance/2470328/VUNO announced that the Food and Drug Administration (FDA) has granted the company 510(k) clearance to market VUNO Med-DeepBrain (VUNO, Seoul, South Korea) in the United States. VUNO Med-DeepBrain is an artificial intelligence (AI)-based software that extracts quantitative data of the brain from
- FDA 510(k) Clearance for AI-Based Software to Assist in the Diagnosis of Sleep Disordershttps://practicalneurology.com/news/fda-510k-clearance-for-ai-based-software-to-assist-in-the-diagnosis-of-sleep-disorders-1/2470307/HoneyNaps announced that the Food and Drug Administration (FDA) has granted the company 510(k) clearance to market SOMNUM (HoneyNaps, Seoul, South Korea) in the United States. SOMNUM is a deep learning artificial intelligence (AI)-based algorithm that analyzes sleep biosignal data obtained from p
- AI-Based Software for Detecting Brain Volumetric Changes Receives FDA 510(k) Clearancehttps://practicalneurology.com/news/ai-based-software-for-detecting-brain-volumetric-changes-receives-fda-510k-clearance/2470303/AIRAmed announced that the Food and Drug Administration (FDA) has granted the company 510(k) clearance to market the AIRAscore (AIRAmed, Tübingen, Germany) software in the United States. AIRAscore provides brain volumetry data based on MRI brain scans using deep learning and artificial intel